VANCOUVER, British Columbia , March 20, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (TSXV: EMH; OTCQX: EMHTF) applauds the Government of Canada for proposing to amend the excise tax calculation for cannabis in the federal budget announced yesterday.

Allan Rewak brings extensive experience with government, media, communications and public affairs VICTORIA, British Columbia , March 18, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ( "Emerald" or the “Company”) (TSXV:EMH; OTCQX:EMHTF) announced today that Allan Rewak has been

Ontario marks a key province to offer Emerald-branded cannabis products, expanding Emerald’s market opportunity to over half of the Canadian cannabis-consuming population VICTORIA, British Columbia , March 14, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc.

Pure Sunfarms’ large-scale facility with 16 grow rooms is optimized for year-round production and expected to yield more than 80 harvests annually VICTORIA, British Columbia , March 11, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) today announced

Novel Emerald endocannabinoid-supporting products well-positioned to develop brand presence and market demand among both cannabis and non-cannabis users SAN DIEGO , March 07, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF)  today announced that its

Verdélite is an essential element of Emerald’s commitment to develop a unique product portfolio for the large Québec marketplace and other provinces, and aims to create approximately 140 jobs in Saint-Eustache SAINT-EUSTACHE, Québec, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics,

VICTORIA, British Columbia , Feb. 13, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms Corp.

Pure Sunfarms Ontario supply agreement adds to Emerald’s existing supply agreement with the Ontario Cannabis Store VICTORIA, British Columbia , Feb. 08, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ( "Emerald" or the “Company”) (TSXV:EMH; OTCQX:EMHTF) today announced its cannabis

Emerald receives certain exclusive rights to established Phytosome ® technology to enhance absorption and bioavailability of cannabinoid products Leading global extraction researcher and manufacturer to provide license of technology and global industrial-scale manufacturing of non-psychotropic

VANCOUVER, British Columbia , Jan. 30, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) announced today that its wholly-owned subsidiary, Verdélite Sciences Inc. (“Verdélite”), which operates a 75,000 square foot indoor cannabis cultivation facility in